Snail1 down-regulation using small interfering RNA complexes delivered through collagen scaffolds
Rosa Viñas-Castells1, Carolyn Holladay, Andrea di Luca
1Network of Excellence for Functional Biomaterials, National University of Ireland, Galway, Ireland.
This study demonstrates a novel collagen scaffold for controlled delivery of small interfering RNA (siRNA) complexes. This biomaterial system effectively down-regulates the Snail1 gene, showing promise for future therapeutic applications.
Area of Science:
- Biomaterials Science
- Gene Therapy
- Molecular Biology
Background:
- Small interfering RNA (siRNA) holds therapeutic potential for diseases like cancer but requires effective delivery systems.
- Controlled release of siRNA is crucial for developing safe and efficient gene therapies.
- Existing delivery methods often lack precise control over siRNA release kinetics.
Purpose of the Study:
- To develop and evaluate a biomaterial scaffold for controlled delivery of siRNA-polymer complexes.
- To assess the efficacy of the scaffold in controlling siRNA release and enhancing transfection efficiency.
- To demonstrate the feasibility of using a collagen scaffold for sustained gene silencing.
Main Methods:
- siRNA was complexed with a polymer and loaded into a collagen biomaterial scaffold.
- The scaffold's ability to control the release of siRNA complexes was investigated.
- Transfection efficiency and gene down-regulation (Snail1) were measured in 2D and 3D culture systems.
- Optimal complexation ratios and dosages were determined.
Main Results:
- A collagen scaffold demonstrated delayed release of siRNA-polymer complexes.
- Over 50% down-regulation of the target gene Snail1 was achieved in 2D cultures at optimal conditions.
- Sustained Snail1 down-regulation was observed for 7 days in a 3D scaffold system.
- The scaffold significantly altered the transfection profile compared to non-scaffolded delivery.
Conclusions:
- A collagen scaffold serves as a feasible controlled release system for siRNA-dendrimer complexes.
- This approach offers a promising strategy for targeted gene silencing in therapeutic contexts.
- The developed system enhances transfection efficiency and provides sustained gene expression modulation.
More Related Videos
07:05TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
12:19Stable Knockdown of Genes Encoding Extracellular Matrix Proteins in the C2C12 Myoblast Cell Line Using Small-Hairpin (sh)RNA
Published on: February 12, 2020
Related Concept Videos
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Small interfering RNAs (siRNA)
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
